Jill Ohar to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Jill Ohar has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.170
-
Ohar J, Tosiello R, Goodin T, Sanjar S. Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4. Int J Chron Obstruct Pulmon Dis. 2019; 14:27-37.
Score: 0.170